慢性心力衰竭诊断及治疗新进展被引量：95

Advances in diagnosis and treatment of chronic heart failure

导出

摘要慢性心力衰竭是一种复杂的临床症状群,发病率和病死率高,5a存活率与恶性肿瘤相仿,严重威胁患者生命。近年来针对心力衰竭的新的诊断与治疗方法不断涌现。本文结合循证医学证据和国内外最新指南,对慢性心力衰竭的诊断及治疗进展作一综述。 Chronic heart failure is a complex group of clinical symptoms with high incidence and fatality threatening human health.Its 5-year survival rate is similar to that of malignant tumor.In recent years,both in terms of basic research and clinical practice,the study on heart failure has made a remarkable progress,and novel screening techniques and therapies have been emerging continuously.This paper reviews the diagnosis and therapy of chronic heart disease based on the latest evidence-based medicine literature and guidelines.

作者王翔易省阳

机构地区海南省人民医院急诊科

出处《中华实用诊断与治疗杂志》 2015年第1期10-12,共3页 Journal of Chinese Practical Diagnosis and Therapy

关键词慢性心力衰竭 B型脑钠肽心脏再同步化治疗 Chronic heart failure B-type brain natriuretic peptide cardiac resynchronization therapy

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献25

1Go AS, Mozaffarian D,Roger VL, et al. Heart disease andstroke statistics-2013 update: a report from the American HeartAssociation[J]. Circulation,2013,127( 1) :e6-e245. 被引量：1
2Chen J, Normand SL, Wang Y, et al. National and regionaltrends in heart failure hospitalization and mortality rates formedicare beneficiaries, 1998-2008 [J]. JAMA, 2011, 306 ( 15):1669-1678. 被引量：1
3Cleland JG, Taylor J, Freemantle N, et al. Relationshipbetween plasma concentrations of N-terminal pro-brainnatriuretic peptide and the characteristics and outcome ofpatients with a clinical diagnosis of diastolic heart failure: areport from PEP-CHF study[J]. Eur J Heart Fail,2012,14(5):487-494. 被引量：1
4Writing Committee Members, Yancy CW, Jessup M,et al.2013 ACCF/AHA guideline for the management of heart failure :a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2013 ,128(16) : e240-327. 被引量：1
5中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量：4652
6Maisel A, Xue Y, Shah K,et al. Increased 90-day mortality inpatients with acute heart failure with elevated copeptin:secondary results from the Biomarkers in Acute Heart Failure(BACH) study[J]. Circ Heart Fail,2011,4(5) :613-620. 被引量：1
7Balling L, Kistorp C,Schou M, et al. Plasma copeptin levelsand prediction of outcome in heart failure outpatients: relation tohyponatremia and loop diuretic doses[J]. J Card Fail,2012,18(5)=351-358. 被引量：1
8Krum H,Massie B, Abraham WT, et al. Direct renin inhibitionin addition to or as an alternative to angiotensin convertingenzyme inhibition in patients with chronic systolic heart failure:rationale and design of the Aliskiren Trial to Minimize Outcomesin Patients with Heart failure (ATMOSPHERE) study[J]. EurJ Heart Fail,2011,13(1) : 107-114. 被引量：1
9McMurray JJ, Packer M, Desai AS,et al. Dual angiotensinreceptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolicheart failure : rationale for and design of the prospectivecomparison of ARNI with ACEI to determine impact on globalmortality and morbidity in heart failure trial (PARADIGM-HF)[J]. Eur J Heart Fail,2013 ,15(9) : 1062-1073. 被引量：1
10Zannad F,McMurray JJ, Krum H, et al. Eplerenone inpatients with systolic heart failure and mild symptoms[J]. NEngl J Med,2011,364(1) :11-21. 被引量：1

二级参考文献19

1YU C M,Bleeker G B,Fung J W. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy[J].Circulation,2005,(11):1580-1586. 被引量：1
2van Bommel R J,Bax J J,Abraham W T. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy:a PROSPECT (Predictors of Response to CRT) sub-analysis[J].European Heart Journal,2009,(20):2470-2477. 被引量：1
3Moss A J,Hall W J,Cannom D S. Cardiacresychronization therapy for the prevention of hear-failure events[J].New England Journal of Medicine,2009,(14):1329-1338. 被引量：1
4Di Biase L,Gasparini M,Lunati M. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy:the InSync ICD (implantable cardioverter-defibrillator) Italian Registry[J].Journal of the American College of Cardiology,2008,(18):1442-1449.doi:10.1016/j.jacc.2008.07.043. 被引量：1
5Lepillier A,Piot O,Gerritse B. Relationship between New York Heart Association class change and ventricular taehyarrhythrnia occurrence in patients treated with cardiac resynchronization plus defibrillator[J].Europace:European Pacing,Arrhythmias and Cardiac Electrophysiology,2009,(01):80-85. 被引量：1
6António N,Teixeira R,Coelho L. Identification of "super-responders" to cardiac resynchronization therapy:the importance of symptom duration and left ventricular geometry[J].Europace:European Pacing,Arrhythmias and Cardiac Electrophysiology,2009,(03):343-349. 被引量：1
7Rickard J,Kumbhani D J,Popovic Z. Characterization of super-response to cardiac resynchronization therapy[J].Heart Rhythm,2010,(07):885-889. 被引量：1
8Lilli A,Ricciardi G,Porciani M C. Cardiac resynchronization therapy:gender related differences in left ventricular reverse remodeling[J].Pacing and Clinical Electrophysiology,2007,(11):1349-1355. 被引量：1
9Xu Y Z,Friedman P A,Webster T. Cardiac resynchronization therapy:do women benefit more than men[J].Journal of Cardiovascular Electrophysiology,2011,(02):172-178. 被引量：1
10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量：3680